10x Genomics (NASDAQ:TXG) Given New $55.00 Price Target at Barclays
10x Genomics (NASDAQ:TXG – Free Report) had its target price upped by Barclays from $45.00 to $55.00 in a report published on Thursday, Benzinga reports. They currently have an overweight rating on the stock. Several other research firms also recently issued reports on TXG. Guggenheim initiated coverage on shares of 10x Genomics in a research […]
More Stories
QRG Capital Management Inc. Trims Position in Sysco Corporation (NYSE:SYY)
QRG Capital Management Inc. trimmed its holdings in shares of Sysco Corporation (NYSE:SYY – Free Report) by 15.2% during the...
Cornerstone Wealth Management LLC Trims Stock Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)
Cornerstone Wealth Management LLC lowered its holdings in T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) by 36.7% in the first...
FCC Reviews ‘Internet of Things’ Accrediting Program Over China Security Concerns
By Lily Zhou The Federal Communications Commission (FCC) is reviewing a cybersecurity program over security concerns related to China, FCC...
Cornerstone Wealth Management LLC Sells 114 Shares of Vanguard Large-Cap ETF (NYSEARCA:VV)
Cornerstone Wealth Management LLC reduced its position in shares of Vanguard Large-Cap ETF (NYSEARCA:VV – Free Report) by 8.0% in...
QRG Capital Management Inc. Makes New $1.34 Million Investment in Expand Energy Corporation (NASDAQ:EXE)
QRG Capital Management Inc. purchased a new position in Expand Energy Corporation (NASDAQ:EXE – Free Report) during the 1st quarter,...
Kingswood Wealth Advisors LLC Has $836,000 Stake in S&P Global Inc. (NYSE:SPGI)
Kingswood Wealth Advisors LLC trimmed its holdings in shares of S&P Global Inc. (NYSE:SPGI – Free Report) by 21.7% during...